Suzhou Fusilai Pharmaceutical Co., Ltd., formerly known as Changshu Fusilai Pharmaceutical Chemical Co., Ltd., started with a factory area of just over 10 acres and has gradually expanded to over 100 acres. The company is located at No. 16 Haiwang Road, Changshu New Materials Industrial Park, Changshu City, Jiangsu Province.

  The company primarily produces three major product series: alpha-lipoic acid, carnosine, and phosphatidylcholine, all of which are high-tech products encouraged under the "biomedicine" category. These products are mainly used in pharmaceuticals, dietary supplements, and cosmetics, offering significant benefits such as antioxidant effects, anti-aging properties, and blood sugar improvement.

  In recent years, the company has experienced rapid growth, becoming one of the larger specialized manufacturers in China for bulk active pharmaceutical ingredients (APIs) and pharmaceutical intermediates, particularly in the alpha-lipoic acid, carnosine, and phosphatidylcholine series. The products are primarily exported and have reached international markets in Europe, America, Southeast Asia, and beyond. The company has established long-term supply and sales partnerships with overseas clients.

  Over the years, the company has focused on source reduction, process pollution control, and the adoption of advanced and effective end-of-pipe treatments to achieve minimal wastewater discharge and total pollution control. It has obtained multiple invention patents and received awards from provincial and municipal authorities. China Environment News has featured the company in a special report.

  The company implements a comprehensive quality management system, organizes production in accordance with GMP requirements, and has passed GMP certification for pharmaceutical APIs and on-site inspections by the U.S. FDA.